Metraipolis › archive › dc_34bbb90d7be4
Locally deployed large language model for real-world lecanemab eligibility pre-screening — Europe PMC PMID:42802831
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42802831
- DOI
- 10.1002/dad2.70495
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-06T15:15:54.445Z
- SHA-256 of the archived text
7e2ff1cf3b7a24676255598114d142c33e3c774140c66626c4915d4013083cb8- Stable URL of this page
https://metraipolis.com/documento/dc_34bbb90d7be4
How to cite
Locally deployed large language model for real-world lecanemab eligibility pre-screening — Europe PMC PMID:42802831 — Europe PMC (en), https://europepmc.org/article/MED/42802831 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_34bbb90d7be4 (Metraipolis archive dc_34bbb90d7be4, sha256 7e2ff1cf3b7a24676255598114d142c33e3c774140c66626c4915d4013083cb8)
BibTeX
@misc{dc34bbb90d7be4,
title = {Locally deployed large language model for real-world lecanemab eligibility pre-screening — Europe PMC PMID:42802831},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42802831},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_34bbb90d7be4; sha256 7e2ff1cf3b7a24676255598114d142c33e3c774140c66626c4915d4013083cb8},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42802831. Agents can read the archived copy with the MCP tool read_document.